AstraZeneca Pharma India Ltd.

Expensive Performer

Check Buy or Sell

3842.90 88.00 (2.34%)

48.09% Gain from 52W Low

47,553 NSE+BSE Volume

NSEMay 14, 2021 03:31 PM

Watchlist

Portfolio

Alert

Share

12S
6W
2O
4T
9,607.3

Market Cap

High in industry

127.1

TTM PE Ratio

High in industry

29.3

TTM PEG Ratio

Market Leader

26.4

Price to Book Ratio

High in industry

0.2

Beta 1Year

Very Low volatility



GET EVENTS ALERTS
New and upcoming Corporate actions, results and board meetings alerts are delivered to your inbox daily in the evening.

Board Meetings - AstraZeneca Pharma India Ltd.

See past and forthcoming board meetings of AstraZeneca Pharma India Ltd. - ASTRAZEN, 506820

Share
Ex-datePurposeNotes
2021-02-08Quarterly Results
2020-11-05Quarterly Results
2020-08-10Quarterly Results & Interim Dividend
2020-05-18Audited Results
2020-02-03Quarterly Results
2019-11-11Quarterly Results
2019-08-07Quarterly Results & Interim Dividend
2019-05-24Audited Results
2019-02-06Quarterly Results
2018-11-13Quarterly Results
2018-08-13Unaudited Financial Results
2018-05-21Audited Results
2018-02-05Quarterly Results
2017-11-06Quarterly Results
2017-08-08Quarterly Results
2017-05-09Audited Results
2017-02-02Quarterly Results
2016-12-02OthersMr. Rajesh Marwaha, Chief Financial Officer of the Company hasbeen inducted into the board as Additional and Whole-time Director. His profile is attached.
2016-11-11Quarterly Results
2016-08-09Quarterly Results
2016-05-25Audited Results
2016-02-06Quarterly Results & OthersThe Board of Directors approved the re-appointment of Mr. Sanjay Murdeshwar as Managing Director of the Company for a period of 3 years, to be effective from May 02, 2016.
2015-12-02OthersDecided to close the Active Pharmaceutical Ingredient Unit (API Unit) situated at 12th Mile on Bellary Road,Venkatala, Yelahanka, Bangalore - 560063.
2015-11-06Quarterly Results & OthersThe Board appointed Ms. Claire-Marie O' Grady as Director of the Company in the vacancy caused by the resignation of Ms. Rebekah Martin with immediate effect.
2015-08-04Quarterly Results
2015-05-27Audited Results
2015-02-11Quarterly Results
2014-11-03Quarterly Results
2014-08-12Quarterly Results
2014-05-30Audited Results
2014-05-05OthersTo consider seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden,Promoter of the company.
2014-04-15OthersTo consider for the voluntary delisting proposed by AstraZeneca Pharmaceuticals Promoter of the Company, in terms of Securities and Exchange Board of India, through Postal Ballot.
2014-03-15OthersTo consider the voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden in terms of their letter dated March 01, 2014 at the meeting of the BOD of the Company held on March 15,2014.
2014-03-05Others
2014-02-10Quarterly Results
2013-11-11Quarterly Results
2013-08-13Quarterly Results
2013-05-21Audited Results
2013-05-06Others
2013-05-02Quarterly Results
2013-02-06Quarterly Results
2012-11-07Quarterly Results
2012-08-10Quarterly Results
2012-05-11Audited & Quarterly Results
2012-02-02Quarterly Results
2011-11-10Quarterly Results
2011-08-08Quarterly Results
2011-06-14Othersinter alia, to consider and approve the proposal of straightening of land boundaries of factory with IDL Industries Ltd.
2011-05-13Audited Results & DividendFifteen Months.
2011-02-08Quarterly Results
2010-10-27Quarterly Results
2010-07-27Quarterly Results & OthersFor seeking the consent / approval of the Shareholders of the Company through postal ballot to the delisting proposal initiated by AstraZeneca Pharmaceuticals, AB, Sweden, promoter of the Company.
2010-07-09OthersThe Board has deferred the decision on delisting proposal initiated by AstraZeneca Pharmaceuticals AB Sweden, promoter of the Company.
2010-06-29Voluntary Delisting of SharesTo make a voluntary delisting offer to the public Shareholders of the Co. in accordance with the SEBI (DES) Regulations, 2009 with a view to delist the Equity Shares from BSE, NSE & BgSE.
2010-04-27OthersThe Board has appointed Ms. Anita Zutshi as the Chief Financial Officer of the Company.
2010-04-26Quarterly Results
2010-03-25Others1. Proposal to augment the Co's Tablet manufacturing plant and facility involving an estimated aggregate outlay of Rs. 70 Crs. 2. Appointment of Mr. Luigi Felice La Corte, as an Additional Director.
2010-02-23Audited Results, Dividend & OthersThe Board has approved the change in the accounting year of the Company from "January-December" to "April-March" & Recommended a Dividend of Rs. 10/- per Equity Share of face value of Rs. 2/- each.
2009-10-27Quarterly Results
2009-07-27Quarterly Results
2009-04-23Quarterly Results
2009-02-18Audited Results & Dividend
2008-10-23Quarterly Results
2008-07-29Quarterly Results
2008-04-28Quarterly Results
2008-02-25Audited Results & Dividend
2007-10-26Quarterly Results
2007-07-26Quarterly Results
2007-04-30Quarterly Results
2007-03-17Interim DividendTo consider the approval of the revised Audited Accounts for the financial year ended December 31, 2006, after incorporating necessary changes as to the revocation of recommended dividend & others.
2007-02-23Accounts & Dividend
2006-10-28Quarterly Results
2006-09-08Issue of fully paid bonus debenturesInter alia, to consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders
2006-08-28Issue of fully paid bonus debenturesTo consider a proposal for issue by the Company of secured fully paid bonus debentures from its General Reserve in terms of a Scheme of Arrangement between the Company and its Shareholders. (deferred)
2006-07-28Quarterly Results
2006-05-09Sub Division of Equity shares
2006-04-29Quarterly Results
2006-02-23Accounts & Dividend
2005-10-20Quarterly Results(Revised)
2005-08-24Accounts
2005-04-27Quarterly Results
2005-02-16Accounts & Dividend(Revised)
2004-10-30Quarterly Results
2004-08-16Quarterly Results
2004-05-31Quarterly Results(Revised)
2004-04-21OthersMr. Bhasker V. Iyer was appinted as an additional Director and Managing Director w.e.f. 06-05-2004.
2004-03-04OthersAstra Pharmaceuticals AB(APAB) a promoter of the company, held 56.50% of the voting share capital of the company in March, 2002.
2004-02-24Dividend & Accounts
2003-11-26Quarterly Results
2003-08-26Quarterly Results
2003-04-28Quarterly Results
2003-02-27Dividend, Accounts & Quarterly Results
2002-10-29Quarterly Results
2002-05-28Quarterly Results
2002-03-14Accounts & Dividend (9 months)
2001-10-17Quarterly Results
2001-07-30Quarterly Results
2001-07-19Quarterly Results(Cancelled)
2001-05-17Qtr Results, Dividend & Accounts
2001-01-18Quarterly Results